TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel SarcopeniaFrailty Treatment at Prestigious International Conference
| TNFA Stock | 1.27 0.09 6.62% |
About 61% of TNF Pharmaceuticals,'s investor base is looking to short. The analysis of overall sentiment of trading TNF Pharmaceuticals, stock suggests that many investors are alarmed at this time. The current market sentiment, together with TNF Pharmaceuticals,'s historical and current headlines, can help investors time the market. In addition, many technical investors use TNF Pharmaceuticals, stock news signals to limit their universe of possible portfolio assets.
TNF |
BALTIMORE, December 09, 2024--TNF Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune and inflammatory conditions, today announced that significant positive topline results from a Phase 2a study of its lead drug candidate MYMD-1 was presented at a prestigious international congress of global experts in sarcopenia and related disorders held December 68, 2024 in Washi
Read at finance.yahoo.com
 |
TNF Pharmaceuticals, Fundamental Analysis
We analyze TNF Pharmaceuticals,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TNF Pharmaceuticals, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TNF Pharmaceuticals, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
TNF Pharmaceuticals, is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
TNF Pharmaceuticals, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TNF Pharmaceuticals, stock to make a market-neutral strategy. Peer analysis of TNF Pharmaceuticals, could also be used in its relative valuation, which is a method of valuing TNF Pharmaceuticals, by comparing valuation metrics with similar companies.
Peers
TNF Pharmaceuticals, Related Equities
| MS | Morgan Stanley | 2.93 | ||||
| SHAK | Shake Shack | 2.45 | ||||
| FRHC | Freedom Holding | 1.48 | ||||
| BYD | Boyd Gaming | 0.67 | ||||
| CBTN | Citizens Bancorp | 0.00 | ||||
| RAND | Rand Capital | 0.00 | ||||
| WEN | Wendys | 0.12 | ||||
| BHM | Bluerock Homes | 0.67 |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance |